These data demonstrate that WHIM24, whose NF1 levels were nearly as low as those in WHIM16, behaved similarly to WHIM16 in that tumor regressed readily after binimetinib addition to fulvestrant (Fig. 5C). The gene discussed is NF1; the disease is neoplasm.